ExLibris header image
SFX Logo
Title: Assessment and Reporting of the Clinical Immunogenicity of Therapeutic Proteins and Peptides—Harmonized Terminology and Tactical Recommendations
Source:

Aaps Journal [1550-7416] yr:2014


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Garcês, S. "The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases : a systematic review of the literature with a meta-analysis." Annals of the rheumatic diseases 72.12 (2012): 1947-1955. Link to SFX for this item
2. "Capillary electrochromatography of proteins and peptides (2006-2015)." Journal of separation science. 40.1: 251-271. Link to SFX for this item
3. Jawa, V. "Review: T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation." Clinical immunology 149.3 (2013): 534-. Link to SFX for this item
4. Nanda, Kavinderjit S. "Impact of Antibodies to Infliximab on Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A Meta-Analysis." The American journal of gastroenterology 108.1 (2012): 40-7. Link to SFX for this item
5. Marine Proteins and Peptides. MDPI - Multidisciplinary Digital Publishing Institute. Link to SFX for this item
6. Coëffier, E. "Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein." Vaccine 19.7-8 (2000): 684-93. Link to Full Text for this item Link to SFX for this item
7. Englund, M. "Prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed biologics." Rheumatology 49.8 (2010): 1563-1569. Link to SFX for this item
8. Radstake, T R D J R. "Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis." Annals of the rheumatic diseases 68.11 (2008): 1739-1745. Link to SFX for this item
9. Erdem, Hatice Rana R. "The effects of sulfasalazine treatment on enthesal abnormalities of inflammatory rheumatic diseases." Clinical rheumatology 26.7 (2007): 1104-10. Link to SFX for this item
10. Ainsworth, Mark A. "Tumor Necrosis Factor-Alpha Binding Capacity and Anti-Infliximab Antibodies Measured by Fluid-Phase Radioimmunoassays as Predictors of Clinical Efficacy of Infliximab in Crohn's Disease." The American journal of gastroenterology 103.4 (2008): 944-948. Link to SFX for this item
11. Lichtenstein, Gary R. "A pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel disease." The American journal of gastroenterology 107.7 (2012): 1051-1063. Link to SFX for this item
12. Steenholdt, C. "Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease." Scandinavian journal of gastroenterology 46.3 (2010): 310-318. Link to SFX for this item
13. Neovius, M. "Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden." Annals of the Rheumatic Diseases 70.4 (2010): 624-9. Link to SFX for this item
14. Cassinotti, A. "Incidence and clinical significance of immunogenicity to infliximab in Crohn's disease: a critical systematic review." Inflammatory bowel diseases 15.8 (2009): 1264-75. Link to SFX for this item
15. Jacobstein, Douglas A A. "Premedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel disease consortium." Inflammatory bowel diseases 11.5 (2005): 442-6. Link to SFX for this item
16. Greenwood, Brian M M. The lancet 365.9469 (2005): 1487-1498. Link to SFX for this item
17. Vermeire, S. "Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease." Gut 56.9 (2007): 1226-1231. Link to Full Text for this item Link to SFX for this item
18. Van Regenmortel, M.H.V.. "Regular Articles: Antigenicity and Immunogenicity of Synthetic Peptides." Biologicals 29.3 (2001): 209-. Link to Full Text for this item Link to SFX for this item
19. Marsh, Sarah A. "Protein Complexes Are under Evolutionary Selection to Assemble via Ordered Pathways." Cell 153.2 (2013): 461-470. Link to SFX for this item
20. Glintborg, B. "Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry." Annals of the Rheumatic Diseases 69.11 (2010): 2002-2008. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.